Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gliosarcoma × palbociclib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Breast Neoplasms 64 Neoplasms 8 Sarcoma 6 Ovarian Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasm Metastasis 5 Sarcoma, Ewing 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4 Glioma 4 Carcinoma, Non-Small-Cell Lung 4 Rhabdomyosarcoma 3 Rhabdoid Tumor 3 Prostatic Neoplasms 3 Osteosarcoma 3 Neuroblastoma 3 Melanoma 3 Medulloblastoma 3 Lymphoma 3 Liposarcoma 3 Endometrial Neoplasms 3 Colorectal Neoplasms 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Wilms Tumor 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lung Neoplasms 2 Kidney Neoplasms 2

Interventions

Temozolomide 46 Radiotherapy 36 Bevacizumab 34 Carmustine 13 Erlotinib Hydrochloride 11 Irinotecan 10 sargramostim 7 Thalidomide 7 Chemotherapy, Adjuvant 7 Carboplatin 7 Radiation 6 pembrolizumab 5 Topotecan 5 Magnetic Resonance Spectroscopy 5 Filgrastim 5 Drug Therapy 5 Cyclophosphamide 5 aldesleukin 4 Tamoxifen 4 Surgical Procedures, Operative 4 Sorafenib 4 O(6)-benzylguanine 4 Gefitinib 4 Etoposide 4 Celecoxib 4 cediranib 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy, Conformal 3 Peripheral Blood Stem Cell Transplantation 3 Imatinib Mesylate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01227434 2015-07-17

PD0332991

University of California, San Francisco

Phase 2 Terminated

23 enrolled 8 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡